The Food and Drug Administration said Thursday it is investigating a possible link between Merck's allergy drug Singulair and suicide.
FDA said it is reviewing reports of mood changes, suicidal behavior and suicide in patients who have taken the drug, which was Merck's best-selling product last year.
In the past year Merck has updated the drug's labeling four times to include information on tremors, anxiousness, depression and suicidal behavior reported in some patients.
Singulair had sales of $4.3 billion last year.
Shares of Merck & Co. Inc. fell 10 cents to $44.60 in late morning trading.
KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.
If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.powered by Disqus